Skip to product information
1 of 1

NSJ Bioreagents

SKU:V9602-100UG

TDRKH Antibody, 100 ug

TDRKH Antibody, 100 ug

Regular price $559.00 USD
Regular price Sale price $559.00 USD
Sale Sold out
Shipping calculated at checkout.
Size

Participates in the primary piRNA biogenesis pathway and is required during spermatogenesis to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for the final steps of primary piRNA biogenesis by participating in the processing of 31-37 nt intermediates into mature piRNAs. May act in pi-bodies and piP-bodies by transferring piRNA precursors or intermediates to or between these granules.

Specifications

Catalog No V9602-100UG
Family Primary antibody
Qty 100 ug
Formulation 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Format Purified
Clone PCRP-TDRKH-1H2
Host Animal Mouse
Clonality Monoclonal (mouse origin)
Isotype Mouse IgG2b
Species Reactivity Human
Application FACS, IF, WB, IHC-P
Application Details Flow cytometry: 1-2ug/million cells,Immunofluorescence: 1-2ug/ml,Western blot: 1-2ug/ml,Immunohistochemistry (FFPE): 1-2ug/ml
Application Note Optimal dilution of the TDRKH antibody should be determined by the researcher.
Localization Cytoplasm
Immunogen Recombinant full-length human TDRKH protein was used as the immunogen for the TDRKH antibody.
Purity Protein A/G affinity
Storage Aliquot the TDRKH antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitation This TDRKH antibody is available for research use only.
Uniprot # Q9Y2W6
Status Available
PDF Link https://www.nsjbio.com/tds-pdf/tdrkh-antibody-pcrp-tdrkh-1h2-v9602
Title TDRKH Antibody
Description Participates in the primary piRNA biogenesis pathway and is required during spermatogenesis to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for the final steps of primary piRNA biogenesis by participating in the processing of 31-37 nt intermediates into mature piRNAs. May act in pi-bodies and piP-bodies by transferring piRNA precursors or intermediates to or between these granules.
View full details